LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical Models. - Brooks NA; Skwarska A; Salama V; Bender MH; Kays L; DeWalt RI; Perria B; Thete D; Manro JR; Cavitt R; Leon R; Gomez S; et al. (Blood cancer discovery, 2026)